Metastatic Gastric Adenocarcinoma Recruiting Phase 0 Trials for Pembrolizumab (DB09037)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05041153Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal AdenocarcinomaTreatment